Latest Breaking News On - Secondary hyperparathyroidism - Page 1 : comparemela.com

Pioneering nephrologist dies at 89

Pioneering nephrologist dies at 89
beckershospitalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from beckershospitalreview.com Daily Mail and Mail on Sunday newspapers.

Eduardo slatopolskyWashington university school of medicineChromalloy american kidney centerWashington universityWashington university schoolPhysician scientistWashington university school of medicineGe 89Kidney diseasesSecondary hyperparathyroidism

Fabry Disease Market is expected to grow at a CAGR of about ~6%

Fabry Disease Market is expected to grow at a CAGR of about ~6%
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesNew yorkHyperparathyroidism market insightsSecondary hyperparathyroidism

HDAC Inhibitor Pipeline Assessment 2024 (Updated): FDA, EMA,

HDAC Inhibitor Pipeline Assessment 2024 (Updated): FDA, EMA,
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew yorkUnited statesHyperparathyroidism market insightsSecondary hyperparathyroidism

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023 - OPKO Health (NASDAQ:OPK)

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ:OPK) will present late-breaking clinical data on RAYALDEE® extended-release calcifediol (ERC) at the American Society of Nephrology (ASN) Kidney

United statesCharlesw bishopAkhtar ashfaqLyvonne briggsBruce vossStephena strugnellHealth incDrug administrationAmerican society of nephrologyExchange commissionAmerican societyKidney weekSecondary hyperparathyroidismExtended release calcifediolExhibit hallsb dCalcifediol overcomes impact

OPKO Health to Present New Clinical Data on Rayaldee (ER

MIAMI, Oct. 25, 2023 (GLOBE NEWSWIRE) OPKO Health, Inc. (NASDAQ: OPK) will present late-breaking clinical data on RAYALDEE® extended-release.

United statesAkhtar ashfaqStephena strugnellBruce vossCharlesw bishopLyvonne briggsHealth incAmerican society of nephrologyDrug administrationExchange commissionAmerican societyKidney weekSecondary hyperparathyroidismExtended release calcifediolExhibit hallsb dCalcifediol overcomes impact